A STRATEGY FOR LAY MINISTRY IN THE NEW TIMESALZMANN R. R.LUTHER. QUART. 1972, Vol 24, Num 2, pp 134-155Article

THE EFFECTS OF TREATMENT AND OF WITHDRAWAL OF TREATMENT WITH GUANFACINE AND CLONIDINE ON BLOOD PRESSURE AND HEART RATE IN NORMOTENSIVE AND RENAL HYPERTENSIVE RATSSALZMANN R.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 4; PP. 212-216; BIBL. 15 REF.Article

THE EFFECT OF INDOMETHACIN ON THE RELEASE OF PROTAGLANDIN E₂ AND ACETYLCHOLINE FROM GUINEA-PIG ISOLATED ILEUM AT REST AND DURING FIELD STIMULATION = EFFET DE L'INDOMETHACINE SUR LA LIBERATION DE PROSTAGLANDINE E₂ ET D'ACETYLCHOLINE A PARTIR DE L'ILEON ISOLE DU COBAYE AU REPOS ET AU COURS DE LA STIMULATION ELECTRIQUEBOTTING JH; SALZMANN R.1974; BRIT. J. PHARMACOL.; G.B.; DA. 1974; VOL. 50; NO 1; PP. 119-124; BIBL. 24REF.Article

INHIBITORY EFFECTS OF CLONIDINE AND BS 100-141 ON RESPONSES TO SYMPATHETIC NERVE STIMULATION IN CATS AND RABBITS = LES EFFETS INHIBITEURS DE LA CLONIDINE ET DU BS 100-141 SUR LES REPONSES A LA STIMULATION NERVEUSE SYMPATHIQUE CHEZ LES CHATS ET LES LAPINSPACHA W; SALZMANN R; SCHOLTYSIK G et al.1975; BRIT. J. PHARMACOL.; G.B.; DA. 1975; VOL. 53; NO 4; PP. 513-516; BIBL. 9REF.Article

Structural studies on chiral (π-allyl)Pd(II) compexes. ¹H, ¹³C and ³¹P NMR studies of [Pd(η³-CH₃CHCHCH₂)(S, S-chiraphos)] CF₃SO₃PREGOSIN, P. S; SALZMANN, R.Magnetic resonance in chemistry. 1994, Vol 32, Num 2, pp 128-133, issn 0749-1581Article

Pharmacological actions of DPN 205-734, a novel cardiotonic agentSALZMANN, R; SCHOLTYSIK, G; MARKSTEIN, R et al.Journal of cardiovascular pharmacology. 1988, Vol 12, Num 4, pp 451-460, issn 0160-2446Article

Sammelberichte. Landschaftlicher Teil Thüringen 1968-1977LUCKERATH, C. A; SALZMANN, R.Blätter für Deutsche Landesgeschichte Wiesbaden. 1980, Vol 116, pp 481-548Article

THE EFFECTS OF THE BETA -ADRENOCEPTOR BLOCKING AGENT LL 21-945 ON RENAL HYPERTENSIVE (GROLLMAN) RATS. = LES EFFETS DE L'AGENT BLOQUANT LES BETA -ADRENOCEPTEURS LL 21945 SURLES RATS EN HYPERTENSION RENALE GROLLMAN)SALZMANN R; ABT K; METZ A et al.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 221; NO 1; PP. 9-20; BIBL. 20 REF.Article

Blaschko-Linien-assoziierte Psoriasis = Psoriasis associated with the lines of BlaschkoSCHOBERT, I; SALZMANN, R.Aktuelle Dermatologie. 1995, Vol 21, Num 7, pp 212-214, issn 0340-2541Article

ANTIHYPERTENSIV WIRKSAME HARNSTOFFDERIVATE DES 8 BETA -AMINOMETHYL-6-METHYL-ERGOLENS. LXXVIII. MITTEILUNG UEBER MUTTERKORNALKALOIDE = ALCALOIDES DE L'ERGOT. LXXVIII. ACTIVITE HYPOTENSIVE DE DERIVES UREIDO DE L'AMINOMETHYL-8 BETA METHYL-6 ERGOLENEFEHR T; STUTZ P; STADLER PA et al.1974; EUROP. J. MEDICIN. CHEM.; FR.; DA. 1974; VOL. 9; NO 6; PP. 597-601; ABS. FR. ANGL.; BIBL. 14 REF.Article

TRAPPING AND INTRAMYOCARDIAL DISTRIBUTION OF MICROSPHERES WITH DIFFERENT DIAMETERS IN CAT AND RABBIT HEARTS IN VITROHOF RP; HOF A; SALZMANN R et al.1981; BASIC RES. CARDIOL.; ISSN 0300-8428; DEU; DA. 1981; VOL. 76; NO 6; PP. 630-638; ABS. GER; BIBL. 18 REF.Article

DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory propertiesSCHOLTYSIK, G; SALZMANN, R; BERTHOLD, R et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 329, Num 3, pp 316-325, issn 0028-1298Article

Pharmacological actions of APP 201-533, a novel cardiotonic agentSALZMANN, R; BORMANN, G; HERZIG, J. W et al.Journal of cardiovascular pharmacology. 1985, Vol 7, Num 3, pp 588-596, issn 0160-2446Article

Pharmacological actions of SDZ 218-135, a novel positive inotropic agentZIERHUT, W; SALZMANN, R; BORMANN, G et al.Cardiovascular drugs and therapy. 1994, Vol 8, Num 2, pp 235-244, issn 0920-3206Article

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma : A randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative GroupKEILHOLZ, U; SWAN HOO GOEY; HANTICH, B et al.Journal of clinical oncology. 1997, Vol 15, Num 7, pp 2579-2588, issn 0732-183XArticle

Heart failure and Ca⁺⁺ activation of the cardiac contractile system: hereditary cardiomyopathy in hamsters (B10 14.6), isoprenaline overload and the effect of APP 201-533HERZIG, J. W; GERBER, W; SALZMANN, R et al.Basic research in cardiology. 1987, Vol 82, Num 4, pp 326-340, issn 0300-8428Article

Cardiovascular actions of DPI 201-106, a novel cardiotonic agentSALZMANN, R; SCHOLTYSIK, G; CLARK, B et al.Journal of cardiovascular pharmacology. 1986, Vol 8, Num 5, pp 1035-1043, issn 0160-2446Article

Digoxin-specific antibody fragments and a calcium antagonist for reversal of digoxin-induced mesenteric vasoconstrictionHESS, T; SCHOLTYSIK, G; SALZMANN, R et al.Journal of pharmacy and pharmacology. 1983, Vol 35, Num 10, pp 647-651, issn 0022-3573Article

X-ray diffraction, multidimensional NMR spectroscopy, and MM2^* calculations on chiral allyl complexes of palladium(II)PREGOSIN, P. S; RÜEGGER, H; SALZMANN, R et al.Organometallics. 1994, Vol 13, Num 1, pp 83-90, issn 0276-7333Article

Kognitive und psychomotorische Leistungsfähigkeit nach Isofluran , Midazolam/Alfentanil : und Propofol-Anästhesie : Eine vergleichende Untersuchung = Recovery of mental and psychomotor skills following general anaesthesia. A comparison of isoflurane, midazolam/alfentanil and propofolMOTSCH, J; BREITBARTH, J; SALZMANN, R et al.Der Anaesthesist (Berlin. Print). 1992, Vol 41, Num 4, pp 185-191, issn 0003-2417Article

Interaction of DPI 201-106 with cardiac glycosidesSCHOLTYSIK, G; SALZMANN, R; GERBER, W et al.Journal of cardiovascular pharmacology. 1989, Vol 13, Num 2, pp 342-347, issn 0160-2446Article

Sprouting and nerve retraction in frog neuromuscular junction during ontogenesis and environmental changesJANS, H; SALZMANN, R; WERNIG, A et al.Neuroscience. 1986, Vol 18, Num 3, pp 773-781, issn 0306-4522Article

PHARMACOLOGICAL ACTIONS OF THE ANTIHYPERTENSIVE AGENT N-AMIDINO-2-(2,6-DICHLOROPHENYL) ACETAMIDE HYDROCHLORIDE (BS 100-141).SCHOLTYSIK G; LAUENER H; EICHENBERGER E et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 10; PP. 1483-1491; ABS. ALLEM.; BIBL. 40 REF.Article

PHARMAKOLOGISCHE WIRKUNGEN DES ANTIHYPERTENSIVUMS 6-BENZOYL-3-HYDRAZINO-5,6,7,8-TETRAHYDROPYRIDO (4,3-C) PYRIDAZIN (BQ-22-708, ENDRALAZIN) = LES ACTIVITES PHARMACOLOGIQUES DE L'ANTIHYPERTENSEUR BENZYL-6 HYDRAZINO-3 TETRAHYDRO-5,6,7,8 PYRIDO (4,3-C) PYRIDAZINE (BQ 22708, ENDRALAZINE)SALZMANN R; BUERKI H; CHU D et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 12; PP. 1843-1853; ABS. ENG; BIBL. 1 P.Article